FDA Approval Application for Mirabegron Submitted by Deva Holding
The FDA has received an application (ANDA219941) for Mirabegron from Deva Holding, currently under standard review.
Asset / Drug
Drug and asset intelligence for Mirabegron with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.